A Pragmatic Randomised Controlled Trial of Tailored Pulmonary Rehabilitation in Participants with Difficult-to-control Asthma and Elevated Body Mass Index

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2022 Sep 24

PMID 36153525

Authors

Helen Clare Ricketts

Varun Sharma

Femke Steffensen

Anna Goodfellow

Elaine Mackay

Gordon MacDonald

Duncan S Buchan

Rekha Chaudhuri

Douglas C Cowan

Affiliations

Soon will be listed here.

Abstract

Background: Difficult-to-control asthma associated with elevated body mass index (BMI) is challenging with limited treatment options. The effects of pulmonary rehabilitation (PR) in this population are uncertain.

Methods: This is a randomised controlled trial of an eight-week asthma-tailored PR programme versus usual care (UC) in participants with difficult-to-control asthma and BMI ≥ 25 kg/m. PR comprised two hours of education and supervised exercise per week, with encouragement for two individual exercise sessions. Primary outcome was difference in change in Asthma Quality of Life Questionnaire (AQLQ) in PR versus UC groups between visits. Secondary outcomes included difference in change in Asthma Control Questionnaire-6 (ACQ6), and a responder analysis comparing proportion reaching minimum clinically important difference for AQLQ and ACQ6.

Results: 95 participants were randomised 1:1 to PR or UC. Median age was 54 years, 60% were female and median BMI was 33.8 kg/m. Mean (SD) AQLQ was 3.9 (+/-1.2) and median (IQR) ACQ6 2.8(1.8-3.6). 77 participants attended a second visit and had results analysed. Median (IQR) change in AQLQ was not significantly different: 0.3 (- 0.2 to 0.6) in PR and - 0.1 (- 0.5 to 0.4) in UC, p = 0.139. Mean change in ACQ6 was significantly different: - 0.4 (95% CI - 0.6 to - 0.2) in PR and 0 (- 0.3 to + 0.3) in UC, p = 0.015, but below minimum clinically important difference. In ACQ6 responder analysis, minimum clinically important difference was reached by 18 PR participants (54.5%) versus 10 UC (22.7%), p = 0.009. Dropout rate was 31% between visits in PR group, and time to completion was significantly prolonged in PR group at 94 (70-107) days versus 63 (56-73) in UC, p < 0.001.

Conclusions: PR improved asthma control and reduced perceived breathlessness in participants with difficult-to-control asthma and elevated BMI. However, this format appears to be suboptimal for this population with high drop-out rates and prolonged time to completion. Trial registration Clinicaltrials.gov. ID NCT03630432. Retrospectively registered, submitted May 26th 2017, posted August 14th 2018.

Citing Articles

Patient-centred outcomes in severe asthma: fatigue, sleep, physical activity and work.

Ten Have L, Meulmeester F, de Jong K, Ten Brinke A Eur Respir Rev. 2025; 34(175).

PMID: 40044187 PMC: 11880904. DOI: 10.1183/16000617.0122-2024.

Immediate and One-Year Outcomes of an Asthma-Tailored Pulmonary Rehabilitation Programme in Overweight and Obese People with Difficult-to-Treat Asthma.

Ricketts H, Sharma V, Steffensen F, Mackay E, MacDonald G, Buchan D J Asthma Allergy. 2024; 17:911-928.

PMID: 39346093 PMC: 11439354. DOI: 10.2147/JAA.S466894.

Protected characteristics reported in pulmonary rehabilitation: a scoping review.

Drover H, Gardiner L, Singh S, Evans R, Daynes E, Orme M Eur Respir Rev. 2024; 33(172).

PMID: 39009405 PMC: 11262624. DOI: 10.1183/16000617.0236-2023.

High-intensity aerobic exercise training improves exercise capacity, dyspnea, and fatigue in patients with severe asthma using triple inhaler.

Jao L, Hsieh P, Wu Y, Tzeng I, Yang M, Su W Tzu Chi Med J. 2024; 36(1):76-82.

PMID: 38406571 PMC: 10887345. DOI: 10.4103/tcmj.tcmj_171_23.

Asthma and its relationship with anthropometric markers among adults.

Alwadeai K, Alhammad S PLoS One. 2023; 18(2):e0281923.

PMID: 36800359 PMC: 9937501. DOI: 10.1371/journal.pone.0281923.

References

Juniper E, Guyatt G, Epstein R, Ferrie P, Jaeschke R, Hiller T . Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992; 47(2):76-83. PMC: 463574. DOI: 10.1136/thx.47.2.76. View

Ortega H, Yancey S, Mayer B, Gunsoy N, Keene O, Bleecker E . Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. Lancet Respir Med. 2016; 4(7):549-556. DOI: 10.1016/S2213-2600(16)30031-5. View

Castro M, Corren J, Pavord I, Maspero J, Wenzel S, Rabe K . Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med. 2018; 378(26):2486-2496. DOI: 10.1056/NEJMoa1804092. View

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

Carson K, Chandratilleke M, Picot J, Brinn M, Esterman A, Smith B . Physical training for asthma. Cochrane Database Syst Rev. 2013; (9):CD001116. DOI: 10.1002/14651858.CD001116.pub4. View

Juniper E, OByrne P, Guyatt G, Ferrie P, King D . Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14(4):902-7. DOI: 10.1034/j.1399-3003.1999.14d29.x. View

Rowlands A, Edwardson C, Davies M, Khunti K, Harrington D, Yates T . Beyond Cut Points: Accelerometer Metrics that Capture the Physical Activity Profile. Med Sci Sports Exerc. 2018; 50(6):1323-1332. DOI: 10.1249/MSS.0000000000001561. View

Griffiths T, Burr M, Campbell I, Mullins J, Shiels K, Payne N . Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000; 355(9201):362-8. DOI: 10.1016/s0140-6736(99)07042-7. View

Sutherland E, Goleva E, Strand M, Beuther D, Leung D . Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med. 2008; 178(7):682-7. PMC: 2556450. DOI: 10.1164/rccm.200801-076OC. View

10.

Jackson D, Busby J, Pfeffer P, Menzies-Gow A, Brown T, Gore R . Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era. Thorax. 2020; 76(3):220-227. PMC: 7892381. DOI: 10.1136/thoraxjnl-2020-215168. View

11.

Camargo Jr C, Weiss S, Zhang S, Willett W, Speizer F . Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med. 1999; 159(21):2582-8. DOI: 10.1001/archinte.159.21.2582. View

12.

Akerman M, Calacanis C, Madsen M . Relationship between asthma severity and obesity. J Asthma. 2004; 41(5):521-6. DOI: 10.1081/jas-120037651. View

13.

McDonald V, Fingleton J, Agusti A, Hiles S, Clark V, Holland A . Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. Eur Respir J. 2019; 53(5). DOI: 10.1183/13993003.02058-2018. View

14.

Vortmann M, Eisner M . BMI and health status among adults with asthma. Obesity (Silver Spring). 2008; 16(1):146-52. DOI: 10.1038/oby.2007.7. View

15.

Turk Y, van Huisstede A, Franssen F, Hiemstra P, Rudolphus A, Taube C . Effect of an Outpatient Pulmonary Rehabilitation Program on Exercise Tolerance and Asthma Control in Obese Asthma Patients. J Cardiopulm Rehabil Prev. 2017; 37(3):214-222. DOI: 10.1097/HCR.0000000000000249. View

16.

Barros R, Moreira P, Padrao P, Teixeira V, Carvalho P, Delgado L . Obesity increases the prevalence and the incidence of asthma and worsens asthma severity. Clin Nutr. 2016; 36(4):1068-1074. DOI: 10.1016/j.clnu.2016.06.023. View

17.

McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y . Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015; (2):CD003793. PMC: 10008021. DOI: 10.1002/14651858.CD003793.pub3. View

18.

Fischer M, Scharloo M, Abbink J, van t Hul A, Van Ranst D, Rudolphus A . Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009; 103(10):1564-71. DOI: 10.1016/j.rmed.2008.11.020. View

19.

Boulet L, Franssen E . Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med. 2007; 101(11):2240-7. DOI: 10.1016/j.rmed.2007.06.031. View

20.

Spruit M, Singh S, Garvey C, ZuWallack R, Nici L, Rochester C . An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013; 188(8):e13-64. DOI: 10.1164/rccm.201309-1634ST. View